Fortress Biotech, Inc.FBIONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-66.14M
↑ 38% vs avg
Percentile
P53
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-106.36M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-66.14M | +30.5% |
| 2024 | $-95.19M | +30.2% |
| 2023 | $-136.32M | +25.3% |
| 2022 | $-182.46M | -37.3% |
| 2021 | $-132.89M | -46.3% |
| 2020 | $-90.85M | +12.9% |
| 2019 | $-104.36M | +3.6% |
| 2018 | $-108.20M | -19.1% |
| 2017 | $-90.88M | -61.4% |
| 2016 | $-56.32M | - |